![The Role of PET and PET/CT in Managing the Care of Lymphoma Patients | Journal of Nuclear Medicine Technology The Role of PET and PET/CT in Managing the Care of Lymphoma Patients | Journal of Nuclear Medicine Technology](https://tech.snmjournals.org/content/jnmt/39/3/190/F2.large.jpg)
The Role of PET and PET/CT in Managing the Care of Lymphoma Patients | Journal of Nuclear Medicine Technology
![18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine 18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/50/1/8/F2.large.jpg)
18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine
![Frontiers | The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma Frontiers | The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma](https://www.frontiersin.org/files/Articles/625436/fonc-11-625436-HTML/image_m/fonc-11-625436-g001.jpg)
Frontiers | The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma
![Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma | Scientific Reports Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-03278-9/MediaObjects/41598_2021_3278_Fig1_HTML.jpg)
Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma | Scientific Reports
![PET/CT and contrast-enhanced CT: making a difference in assessment and staging of patients with lymphoma | Egyptian Journal of Radiology and Nuclear Medicine | Full Text PET/CT and contrast-enhanced CT: making a difference in assessment and staging of patients with lymphoma | Egyptian Journal of Radiology and Nuclear Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43055-020-00320-0/MediaObjects/43055_2020_320_Fig8_HTML.png)
PET/CT and contrast-enhanced CT: making a difference in assessment and staging of patients with lymphoma | Egyptian Journal of Radiology and Nuclear Medicine | Full Text
![FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dc07ffcd-e705-4ac2-894c-903d23bbb772/joim12813-fig-0003-m.jpg)
FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library
![FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/670ee159-b761-4ad7-8fb9-b336be7e0bf2/joim12813-fig-0001-m.jpg)
FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library
![Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-020-00681-7/MediaObjects/13550_2020_681_Fig1_HTML.png)
Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text
![Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma | Scientific Reports Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-22032-3/MediaObjects/41598_2022_22032_Fig1_HTML.jpg)
Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma | Scientific Reports
![A remarkable case of extranodal Hodgkin lymphoma monitored with F-18 FDG PET /CT - International Journal of Case Reports and Images (IJCRI) A remarkable case of extranodal Hodgkin lymphoma monitored with F-18 FDG PET /CT - International Journal of Case Reports and Images (IJCRI)](https://www.ijcasereportsandimages.com/archive/2021/images/figure1.1627293136.jpg)
A remarkable case of extranodal Hodgkin lymphoma monitored with F-18 FDG PET /CT - International Journal of Case Reports and Images (IJCRI)
![The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology](https://www.thelancet.com/cms/attachment/fde9dfe2-9e87-40ba-9a1c-03d0ac9138ed/gr1_lrg.jpg)
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology
![Biomedicines | Free Full-Text | Radiotherapy in Follicular Lymphoma Staged by 18F-FDG-PET/CT: A German Monocenter Study Biomedicines | Free Full-Text | Radiotherapy in Follicular Lymphoma Staged by 18F-FDG-PET/CT: A German Monocenter Study](https://www.mdpi.com/biomedicines/biomedicines-09-00561/article_deploy/html/images/biomedicines-09-00561-g001.png)